Ucl Business PLC
Records under this name other than the patents Ucl Business PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 67 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,163,482 | BBS10 Related Diagnostic Methods for Bardet-Biedl Syndrome Formerly held In force · High confidence | In force | High confidence | |
| US 7,820,624 | Peptide ligands Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,252,851 | Formulations and composites with reactive fillers Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,642,072 | Membrane Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,889,179 | Membrane Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,669,347 | Truncated variant of the mammalian target for rapamycin (MTOR) protein Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,771,645 | Composition comprising a cell death marker and a wavelength-optimized label Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,266,620 | Treatment of Portal Hypertension and Restoration of Liver Function Using L-Ornithine Phenylacetate Formerly held In force · High confidence | In force | High confidence | |
| US 9,399,016 | Materials and complexes for the delivery of biologically-active materials to cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,764,045 | Optimised Coding Sequence and Promoter Formerly held In force · Medium confidence | In force | Medium confidence |